Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Hepatocellular 37Liver Neoplasms 18Neoplasm Metastasis 17Colorectal Neoplasms 13Cholangiocarcinoma 11Pancreatic Neoplasms 9Lung Neoplasms 8Colonic Neoplasms 8Breast Neoplasms 8Barrett Esophagus 7Recurrence 6Carcinoma, Renal Cell 6Carcinoma, Non-Small-Cell Lung 6Thyroid Neoplasms 5Rectal Neoplasms 5Thyroid Nodule 4Pain 4Neoplasms 4Kidney Neoplasms 4Esophageal Neoplasms 4Thyroid Cancer, Papillary 3Biliary Tract Neoplasms 3Agnosia 3Thyroid Diseases 2Prostatic Neoplasms 2Leiomyoma 2Hyperaldosteronism 2Cancer Pain 2Bile Duct Neoplasms 2Uterine Cervical Neoplasms 1

Interventions

Radiofrequency Ablation 1Gemcitabine 1Endoscopic Ultrasound-Guided Fine Needle Aspiration 1Cholangiopancreatography, Endoscopic Retrograde 1Albumin-Bound Paclitaxel 13-(2-(2-tert-butylphenylaminooxalyl)aminopropionylamino)-4-oxo-5-(2,3,5,6-tetrafluorophenoxy)pentanoic acid 1130-nm albumin-bound paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Cholestasis × Radiofrequency Ablation × Clear all
NCT02582541 2015-10-21

Endoscopic Biliary RFA of Malignant Bile Duct Obstruction

The Second Hospital of Nanjing Medical University

Phase NA Unknown
100 enrolled
Gastrointestinal

Cholestasis, Cholangiocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡